WST Relative Valuation
WST's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, WST is overvalued; if below, it's undervalued.
Historical Valuation
No Data
Competitors Valuation Multiple
The average P/S ratio for WST's competitors is 3.16, providing a benchmark for relative valuation. West Pharmaceutical Services Inc Corp (WST) exhibits a P/S ratio of 5.18, which is 63.79% above the industry average. Given its robust revenue growth of 0.37%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is West Pharmaceutical Services Inc (WST) currently overvalued or undervalued?
What is West Pharmaceutical Services Inc (WST) fair value?
How does WST's valuation metrics compare to the industry average?
What is the current P/B ratio for West Pharmaceutical Services Inc (WST) as of May 19 2025?
What is the current FCF Yield for West Pharmaceutical Services Inc (WST) as of May 19 2025?
What is the current Forward P/E ratio for West Pharmaceutical Services Inc (WST) as of May 19 2025?